SMARTPHARMA BIOMEDICAL CO.,LTD

Company: SMARTPHARMA BIOMEDICAL CO.,LTD

Location: Taiwan

Business Type: Manufacturer (Factory)

Company Introduction:

SMARTPHARMA BIOMEDICAL CO.,LTD is a Taiwanese company dedicated to the research, development, manufacturing, and distribution of advanced medical devices and related healthcare products. The company primarily specializes in the ophthalmology sector, offering innovative solutions for eye care. Emphasizing technological innovation and strict quality control, SMARTPHARMA BIOMEDICAL strives to improve patient outcomes and elevate healthcare standards with its high-quality medical products. Their operations cover the entire product lifecycle, from conceptualization and design through to production and market distribution, clearly positioning them as a manufacturing enterprise within the biomedical industry.

SMARTPHARMA BIOMEDICAL CO.,LTD Products

SmartPharma Biomedical Co., Ltd. focuses on the development and commercialization of pharmaceutical products, particularly in the areas of oncology and autoimmune diseases. Their product pipeline includes:

SP101 (Pemetrexed): A generic version of Alimta, used for the treatment of non-small cell lung cancer and mesothelioma.

SP201 (Gemcitabine): A generic version of Gemzar, used for the treatment of various cancers including breast, ovarian, non-small cell lung, and pancreatic cancer.

SP301 (Docetaxel): A generic version of Taxotere, used for the treatment of breast, prostate, stomach, head and neck, and non-small cell lung cancer.

SP401 (Irinotecan): A generic version of Camptosar, used for the treatment of colorectal cancer.

SP501 (Oxaliplatin): A generic version of Eloxatin, used for the treatment of colorectal cancer.

SP601 (Bevacizumab biosimilar): A biosimilar to Avastin, used for the treatment of various cancers including colorectal, lung, brain, kidney, and ovarian cancer.

SP701 (Rituximab biosimilar): A biosimilar to Rituxan, used for the treatment of non-Hodgkin's lymphoma, chronic lymphocytic leukemia, rheumatoid arthritis, and other autoimmune diseases.

SP801 (Trastuzumab biosimilar): A biosimilar to Herceptin, used for the treatment of HER2-positive breast cancer and gastric cancer.

They also engage in contract manufacturing and research services for other pharmaceutical companies.